Biovie Inc.
BIVI· Nasdaq
Filed Jan 29, 2021 · 10-Q · 29 days after period end · 0001520138-21-000081
| Metric | Q2 2021 | Q2 2020 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$3.06M | $6.67M | -$357.80K | -$49.88K |
| EPS Diluted | -$0.22 | $1.29 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Jan 29, 2021 · 29 d after period end